Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 24,233 shares at $15.72 ($392K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($392k) by Chief Scientific Officer — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.72 | 10,000 | $157K | 40.1% |
| 2 | $16.52 | 14,233 | $235K | 59.9% |
| Total | $16.19 avg | 24,233 | $392K | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |